Related Experiment Video
Updated: Jun 28, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Mortality Impact of Stroke and Major Bleeding across the Ejection Fraction Spectrum in Patients Hospitalized for
Jumpei Yamamoto1,2, Keijiro Nakamura3, Hiromasa Hayama4
1Division of Cardiovascular Medicine, Toho University Medical Center Ohashi Hospital, Tokyo, Japan, 09106y@gmail.com.
Insights
In patients with acute heart failure and atrial fibrillation, major bleeding increased mortality risk, while stroke risk was uncertain. Bleeding risk mitigation is advised alongside stroke prevention.
Area of Science:
- Cardiology
- Neurology
- Geriatrics
Background:
- Investigating differential mortality impacts of ischemic stroke and major bleeding across left ventricular ejection fraction (LVEF) categories in acute heart failure (AHF) patients with atrial fibrillation (AF).
- Uncertainty exists regarding how stroke and bleeding events affect mortality differently based on heart failure severity (HFrEF, HFmrEF, HFpEF).
Purpose of the Study:
- To determine if the mortality risk associated with ischemic stroke and major bleeding varies among patients hospitalized for AHF with AF, stratified by LVEF.
- To analyze the association between post-stroke and post-bleeding states and subsequent all-cause and cardiovascular mortality.
Main Methods:
- Retrospective analysis of 716 patients hospitalized for AHF with AF.
- Follow-up for up to 3 years to record stroke, major bleeding, and mortality events.
- Time-dependent Cox models used to assess mortality associations, stratified by LVEF categories (HFrEF, HFmrEF, HFpEF).
Main Results:
- Post-major bleeding was linked to increased all-cause mortality (HR 2.00, 95% CI 1.22-3.28).
- The association between post-stroke status and all-cause mortality was imprecise (HR 1.35, 95% CI 0.67-2.70).
- Neither stroke nor bleeding reached conventional statistical significance for cardiovascular death; LVEF-stratified results were imprecise.
Conclusions:
- In AHF patients with AF, developing major bleeding increased subsequent all-cause mortality, while stroke's impact was less clear.
- Limited event counts and non-significant interaction tests precluded definitive LVEF-stratified conclusions.
- Mitigating bleeding risk is crucial, but should complement, not replace, ongoing stroke prevention strategies.
Introduction:
Whether the mortality impact of ischemic stroke and major bleeding differs across left ventricular ejection fraction (LVEF) categories in patients hospitalized for acute heart failure (AHF) with atrial fibrillation (AF) remains uncertain.
Methods:
We retrospectively analyzed 716 patients hospitalized for AHF with prevalent AF (mean age: 79 ± 11 years; 49% female). During up to 3 years of follow-up (median: 1.4 years), 53 patients developed stroke and 89 developed major bleeding. Time-dependent Cox models were used to evaluate associations between poststroke and post-major bleeding states and all-cause and cardiovascular mortality, stratified by LVEF category: heart failure with reduced ejection fraction, mildly reduced ejection fraction, and preserved ejection fraction.
Results:
There were 160 deaths, including 106 cardiovascular deaths. As first qualifying events, 34 were stroke-first, and 74 were bleeding-first, with the remaining patients experiencing death-first or being censored. In time-dependent Cox models, post-major bleeding status was associated with higher all-cause mortality, whereas the poststroke association was imprecise (hazard ratio [HR] 2.00, 95% confidence interval [CI] 1.22-3.28 vs. HR 1.35 [95% CI 0.67-2.70]). For cardiovascular death, neither exposure reached conventional statistical significance (HR 1.97 [95% CI 0.93-4.17] after stroke and 1.69 [0.88-3.26] after bleeding). LVEF-stratified estimates were imprecise, and interaction tests did not support definitive effect modification.
Conclusion:
In patients hospitalized for AHF with prevalent AF, transition into a post-major bleeding state was associated with higher subsequent all-cause mortality, whereas the poststroke association was imprecise. LVEF-stratified findings were exploratory because interaction tests were not significant and event counts were limited. Bleeding-risk mitigation should accompany continued stroke prevention, not replace it.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Pathophysiology of Heart Failure
